Provided by Tiger Trade Technology Pte. Ltd.

Mirum Pharmaceuticals, Inc.

105.16
-0.3300-0.31%
Post-market: 105.160.00000.00%19:57 EST
Volume:606.18K
Turnover:63.68M
Market Cap:6.30B
PE:-125.29
High:106.34
Open:105.32
Low:102.51
Close:105.49
52wk High:107.41
52wk Low:36.88
Shares:59.88M
Float Shares:39.99M
Volume Ratio:0.94
T/O Rate:1.52%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8393
EPS(LYR):-1.8505
ROE:-15.81%
ROA:-3.60%
PB:21.56
PE(LYR):-56.83

Loading ...

Travere Q4 product sales surge on FILSPARI growth

Reuters
·
Yesterday

Assessing Mirum Pharmaceuticals (MIRM) Valuation After Recent Share Price Momentum And Rare Disease Growth Prospects

Simply Wall St.
·
Feb 19

Mirum Pharmaceuticals Inc. updates financial calendar

Reuters
·
Feb 19

Mirum Can Sustain Revenue Growth with Multiple Catalysts, RBC Says

MT Newswires Live
·
Feb 18

Mirum Pharmaceuticals Director Saira Ramasastry Reports Sale of Common Shares

Reuters
·
Feb 18

Mirum Pharmaceuticals Grants Stock Options and Equity Awards to New Employees

Reuters
·
Feb 11

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Feb 11

Mirum Pharmaceuticals Announces Health Canada Authorization of Livmarli® Tablet Formulation for the Treatment of Cholestatic Pruritus in Patients With Alagille Syndrome

THOMSON REUTERS
·
Feb 05

Health Canada genehmigt LIVMARLI von Mirum Pharmaceuticals zur Behandlung von cholestatischem Pruritus bei PFIC

Reuters
·
Feb 05

Mirum Pharmaceuticals Announces Health Canada Authorization of Livmarli® for the Treatment of Cholestatic Pruritus in Patients With Progressive Familial Intrahepatic Cholestasis (Pfic)

THOMSON REUTERS
·
Feb 05

Mirum Pharmaceuticals Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Jan 31

Mirum Pharmaceuticals Inc : TD Cowen Raises Target Price to $115 From $95

THOMSON REUTERS
·
Jan 29

Mirum Pharmaceuticals director buys $9.0M in common stock

TIPRANKS
·
Jan 28

Mirum Pharmaceuticals CEO Christopher Peetz Reports Disposal of Common Shares

Reuters
·
Jan 28

Mirum Pharmaceuticals Completes Acquisition of Bluejay Therapeutics

Reuters
·
Jan 26

Mirum Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Jan 26

Mirum Pharmaceuticals Inc : Leerink Partners Raises Target Price to $105 From $100

THOMSON REUTERS
·
Jan 26

Mirum Pharmaceuticals price target raised to $130 from $102 at H.C. Wainwright

TIPRANKS
·
Jan 26

HBM Healthcare Investments Reports CHF 286 Million Profit for First Nine Months of 2025/2026

Reuters
·
Jan 23

Evercore ISI Reaffirms Their Buy Rating on Mirum Pharmaceuticals (MIRM)

TIPRANKS
·
Jan 20